Notably, silencing ALT2 in the liver of obese mice has been reported to diminish alanine-induced hyperglycemia while concurrently elevating serum alanine levels, suggesting a regulatory feedback mechanism pertinent to alanine metabolism in obesity [61]. Here, GPT2 is linked to obesity due to melanocortin 4 receptor deficiency.